… studies. In vaccines, Gardasil sales were $1 billion … treated with a statin, will be presented … novel anchor medicine across multiple two-drug treatment regimens, providing … trials evaluating izlotrovir and lenacapavir as a once-weekly oral two-drug treatment …

… have been published in Nature Medicine on World Cancer Day. The … headed the Indian Council of Medical Researchers – National Institute of Cancer … Programme. Currently, three vaccines—Cervarix, Gardasil 4 and the indigenous Cervavac …

… to 2024 results. The pharmaceutical segment contributed $57.5 … .4 billion (+7%), while Gardasil sales declined 35% to $1 … positive Phase 3 clinical trial readouts. The company introduced … disease. Regulatory updates included FDA priority reviews for several …

… affordable, recommended by all medical organisations. “Screening tests … and immunotherapy. “Timely treatment from expert oncologists can provide … to eligible beneficiaries is Gardasil-4, which protects … ;Shortage of life-saving drugs: Inside the supply chain …

… , and you dealt with Gardasil pressures all year long,” … in 2028 for blockbuster cancer drug Keytruda, which comes off … flirtation and breakup with Revolution Medicines, a deal that could … Winrevair, approved by the FDA for pulmonary arterial hypertension in …

… its animal health division, pharmaceutical sales specifically contributed $58 … picks up. HPV vaccine Gardasil, meanwhile, again bogged … arterial hypertension (PAH) drug Winrevair, meanwhile, lived up … interest in buying Revolution Medicines for up to $ …

… drugmaker prepares for the loss of exclusivity of several of its medicines … , while type 2 diabetes drugs Januvia (sitagliptin) and neuromuscular … was looking to buy Revolution Medicines for up to $32bn, … mid-2030s. MSD’s Gardasil vaccines did not perform well …

… .19 billion. Segment And Drug Performance The pharmaceutical segment recorded $14.84 … global demand in metastatic indications. GARDASIL and GARDASIL 9, vaccines to prevent … $5.38. The U.S. drug giant expects 2026 sales between …

… , with pulmonary arterial hypertension drug Winrevair posting $467m in … sharp decline in vaccines, notably Gardasil, whose fourth-quarter sales … “manageable” effects from its drug-pricing agreement with the US … from 18 phase three trials in 2025 and roughly …

… a biotech company that is developing a flu prevention drug.  … voluntarily sell its existing treatments to Medicaid patients at the … s pharmaceutical unit, which develops a wide range of drugs, … , according to StreetAccount. Gardasil’s revenue could face …